Jianjun Wang, Ph.D., Founder and Chief Scientist 

Troy, Michigan 


Virtual Presentation 

Qurgen gathers the world’s top professional talents in iPS stem cells and the regenerative medical research field. The company is committed to establishing its stem cells technology platform and R&D and clinical translation based on its protein induced in-situ cell reprogramming technology. The company will also manufacture and sell QQ proteins, iPS stem cells, and cell lines. At the same time, the company will apply developed core technologies in therapeutic area including several serious diseases, developing new treatment methods and drugs for clinic disease. 


By using this website you agree to accept our Privacy Policy and Terms & Conditions